Techniques in Vascular & Interventional Radiology
Volume 7, Issue 1 , Pages 28-32 , March 2004

Drug eluting stents in the infrainguinal circulation

  • Lindsay Machan, MD

      Affiliations

    • Head Angiography and Interventional Radiology, Department of Radiology, Vancouver Hospital and Health Sciences Center, Vancouver, BC, Canada
    • Corresponding Author InformationAddress reprint requests to Lindsay Machan, MD, Department of Radiology, University of British Columbia Hospital, 2211 Wesbrook Mall, Vancouver, BC, Canada V6T 2B5

References 

  1. Management of Peripheral Arterial Disease (PAD) . TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2003;31:S103–S108
  2. Jamsen TS, Manninen HI, Jaakkola PA, et al.  Long-term outcome of patients with claudication after balloon angioplasty of the femoropopliteal arteries. Radiology. 2002;225:345–352
  3. Jahnke T, Voshage G, Muller-Hulsbeck S, et al.  Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. JVIR. 2002;13:257–266
  4. Mewisson MW. Nitinol Stents in the Femoropopliteal Arterial Segment. Endovascular Today. 2003;2:29–34
  5. Virmani R, Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol. 1999;10:499–506
  6. Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: drug-eluting stents: Part I. Circulation. 2003;107:2274–2279
  7. Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: drug-eluting stents: Part II. Circulation. 2003;107:2383–2389
  8. Marx SQ, Marks AR. Bench to bedside (the development of rapamycin and its application to stent restenosis). Circulation. 2001;104:852–855
  9. Moses JW, Leon MB, Popma JJ, et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  10. Signore P, Machan LS, Jackson J, et al.  Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries. J Vasc Interv Radiol. 2001;12:79–88
  11. Hong MK, Mintz GS, Lee CW, et al.  Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries (A serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT)). Circulation. 2003;107:517–520
  12. Grube E, Bullesfeld L. experience with paclitaxel-coated stents. J Interv Cardiol. 2002;15:471–475
  13. Stone GW. Taxus IV Results. Presented at TCT. 2003; Annual Meeting, Washington, DC
  14. Serruys PW, Foley DP, Kirkeeide RL, et al.  Restenosis revisited (Insights provided by quantitative coronary angiography). Am Heart J. 1993;126:1243–1267
  15. Duda SH, Pusich B, Richter G, et al.  Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease (Six-month results). Circulation. 2002;106:1505–1509
  16. Duda SH. The SIROCCO trial. Presented at TCT. 2003; Annual Meeting, Washington, DC
  17. Faglia E, Mantero M, Caminiti M, et al.  Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers (clinical results of a multicentric study of 221 consecutive diabetic subjects). J Intern Med. 2002;52:225–232
  18. Schmidt A, Ropers S, Braunlich S, et al.  Drug-Eluting Stents for the Treatment of Obstructive Disease in Infrapopliteal Arteries. Poster presentation #362 at TCT. 2003; Annual Meeting, Washington, DC

PII: S1089-2516(04)00005-8

doi: 10.1053/j.tvir.2004.01.004

Techniques in Vascular & Interventional Radiology
Volume 7, Issue 1 , Pages 28-32 , March 2004

Article Tools

* Image Usage & Resolution